Humira Under Pressure As NHS England Invites 'Competitive Prices' For Biosimilars

 
• By Ian Schofield
  
Seesaw
Price will be a key factor in the biosimilar adalimumab market
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics